Article(id=1329527025729122615, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329526884620153211, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.04.017, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1684166400000, receivedDateStr=2023-05-16, revisedDate=1704988800000, revisedDateStr=2024-01-12, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913544351, onlineDateStr=2026-11-17, pubDate=1712678400000, pubDateStr=2024-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913544351, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913544351, creator=13701087609, updateTime=1794913544351, updator=13701087609, issue=Issue{id=1329526884620153211, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='4', pageStart='349', pageEnd='444', issueExtLink='null', onlineDate='null', pubDate='1712678400000', pubDateStr='2024-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913510708, creator='13701087609', updateTime=1794962107180, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329730713529725122, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329526884620153211, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329730713529725123, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329526884620153211, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=440, endPage=444, ext={EN=ArticleExt(id=1329527025951420728, articleId=1329527025729122615, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on oral prostaglandin in the treatment of pulmonary hypertension, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Pulmonary arterial hypertension (PAH) is a progressive and treatable disease characterized by contraction and remodeling of pulmonary arteriole accompanied by increased pulmonary arterial pressure. As PAH progresses, the load on the right ventricle increases, eventually leading to heart failure. Oral prostaglandin (PG) and their analogues can improve the clinical symptoms of PAH, reduce the risk of deterioration or death, delay disease progression, and are relatively safe, convenient, and have high patient compliance. This article reviewed the mechanism and application of oral PG in the treatment of PAH and provided a basis for clinical application.

, authors=Yi LI, Guangwei WU, Haitong ZHU, Mengyi HUANG, authorsList=Yi LI, Guangwei WU, Haitong ZHU, Mengyi HUANG, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329527026186301753, articleId=1329527025729122615, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=口服前列腺素治疗肺动脉高压研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

肺动脉高压(pulmonary arterial hypertension,PAH)是一种进行性的、治愈难度大的疾病,其特征为肺小动脉的收缩与重塑,同时伴肺动脉压力增加。随着PAH进展,右心室负荷增加,最终发展为心力衰竭(heart failure)。口服前列腺素(prostaglandin,PG)及其类似物能改善PAH临床症状、降低恶化/死亡风险、延缓疾病进展,且相对安全、方便,患者依从性高。现对口服PG治疗PAH机制及应用相关文献进行综述,为临床提供决策依据。

, authors=李义, 伍广伟, 朱海通, 黄梦怡, authorsList=李义, 伍广伟, 朱海通, 黄梦怡, authorCompany=null, correspAuthors=null, authorNote=

李义,主治医师,研究方向:肺动脉高压诊治。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=DGpshfyg/Jp4wlLrb4+2Zw==, magXml=U3S32/i4v6aXjRicSUO5uA==, pdfUrl=null, pdf=lHtz9SomZXaq5y9VLXRWIQ==, pdfFileSize=1566920, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=OnTWeTQ7W4Vi0wGnJytP3A==, mapNumber=null, fund=null)}, authors=[Author(id=1329527026458931518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527026551206208, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026458931518, language=EN, stringName=Yi LI, firstName=Yi, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527026630897985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026458931518, language=CN, stringName=李义, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=广西壮族自治区人民医院心血管内科,广西 南宁 530016, bio={"content":"

李义,主治医师,研究方向:肺动脉高压诊治。

"}, bioImg=null, bioContent=

李义,主治医师,研究方向:肺动脉高压诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])]), Author(id=1329527026710589763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527026790281541, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026710589763, language=EN, stringName=Guangwei WU, firstName=Guangwei, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527026874167622, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026710589763, language=CN, stringName=伍广伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=广西壮族自治区人民医院心血管内科,广西 南宁 530016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])]), Author(id=1329527026991608136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527027092271434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026991608136, language=EN, stringName=Haitong ZHU, firstName=Haitong, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527027180351819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026991608136, language=CN, stringName=朱海通, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=广西壮族自治区人民医院心血管内科,广西 南宁 530016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])]), Author(id=1329527027264237901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527027360706895, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527027264237901, language=EN, stringName=Mengyi HUANG, firstName=Mengyi, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527027452981584, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527027264237901, language=CN, stringName=黄梦怡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=广西壮族自治区人民医院心血管内科,广西 南宁 530016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])])], keywords=[Keyword(id=1329527029218783569, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=EN, orderNo=1, keyword=oral prostaglandin), Keyword(id=1329527029508190546, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=EN, orderNo=2, keyword=pulmonary arterial hypertension), Keyword(id=1329527029604659539, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=EN, orderNo=3, keyword=troprostacycline), Keyword(id=1329527029684351316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=EN, orderNo=4, keyword=bayprostaglandin), Keyword(id=1329527029789208917, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=EN, orderNo=5, keyword=selexipag), Keyword(id=1329527029873094998, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=EN, orderNo=6, keyword=ralinepag), Keyword(id=1329527029956981079, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=CN, orderNo=1, keyword=口服前列腺素), Keyword(id=1329527030040867160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=CN, orderNo=2, keyword=肺动脉高压), Keyword(id=1329527030124753241, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=CN, orderNo=3, keyword=曲前列环素), Keyword(id=1329527030237999450, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=CN, orderNo=4, keyword=贝前列腺素), Keyword(id=1329527030409965915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=CN, orderNo=5, keyword=司来帕格), Keyword(id=1329527030523212124, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, language=CN, orderNo=6, keyword=雷利帕格)], refs=[Reference(id=1329527030657429853, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Respir J, 2023, 61(1): 2200879., articleTitle=null, refAbstract=null), Reference(id=1329527030732927326, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Gelzinis TA. Pulmonary hypertension in 2021: part Ⅰ- definition, classification, pathophysiology, and presentation[J]. J Cardiothorac Vasc Anesth, 2022, 36(6): 1552-1564., articleTitle=null, refAbstract=null), Reference(id=1329527030812619103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Safdar Z. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs[J]. Respir Med, 2011, 105(6): 818-827., articleTitle=null, refAbstract=null), Reference(id=1329527030900699488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Mandras S, Kovacs G, Olschewski H, et al. Combination therapy in pulmonary arterial hypertension-targeting the nitric oxide and prostacyclin pathways[J]. J Cardiovasc Pharmacol Ther, 2021, 26(5): 453-462., articleTitle=null, refAbstract=null), Reference(id=1329527031001362785, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review[J]. J Am Med Assoc, 2022, 327(14): 1379-1391., articleTitle=null, refAbstract=null), Reference(id=1329527031106220386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=王志伟, 韩宇, 程江涛. 司来帕格在肺动脉高压治疗中的应用[J]. 中国药房, 2022, 33(16): 2040-2043., articleTitle=null, refAbstract=null), Reference(id=1329527031219466595, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Mubarak KK. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension[J]. Respir Med, 2010, 104(1): 9-21., articleTitle=null, refAbstract=null), Reference(id=1329527031307546980, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Tuder RM, Cool CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension[J]. Am J Respir Crit Care Med, 1999, 159(6): 1925-1932., articleTitle=null, refAbstract=null), Reference(id=1329527031441764709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Patel JA, Shen L, Hall SM, et al. Prostanoid EP2 receptors are up-regulated in human pulmonary arterial hypertension: a key anti-proliferative target for treprostinil in smooth muscle cells[J]. Int J Mol Sci, 2018, 19(8): 2372., articleTitle=null, refAbstract=null), Reference(id=1329527031542428006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Mulvaney EP, Reid HM, Bialesova L, et al. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension[J]. Bio Med Central Pulm Med, 2020, 20(1): 85., articleTitle=null, refAbstract=null), Reference(id=1329527031634702695, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=陈雨思, 李江. 前列环素类药物治疗肺动脉高压的研究进展[J]. 医药导报, 2022, 41(2): 195-200., articleTitle=null, refAbstract=null), Reference(id=1329527031848612200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Tapson VF, Torres F, Kermeen F, et al. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial[J]. Chest, 2012, 142(6): 1383-1390., articleTitle=null, refAbstract=null), Reference(id=1329527031961858409, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Tapson VF, Jing Z, Xu K, et al. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study)[J]. Chest, 2013, 144(3): 952-958., articleTitle=null, refAbstract=null), Reference(id=1329527033719271786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=White RJ, Jerjes-Sanchez C, Bohns Meyer GM, et al. Combination therapy with oral treprostinil for pulmonary arterial hypertension. A double-blind placebo-controlled clinical trial[J]. Am J Respir Crit Care Med, 2020, 201(6): 707-717., articleTitle=null, refAbstract=null), Reference(id=1329527034029650283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Khan A, White RJ, Meyer G, et al. Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension[J]. Respiratory Medicine, 2022, 193: 106744., articleTitle=null, refAbstract=null), Reference(id=1329527034142896492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=White RJ, Parikh K, Allen R, et al. EXPRESS: long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics[J]. Pulm Circ, 2019, 10(4): 2045894019866335., articleTitle=null, refAbstract=null), Reference(id=1329527034239365485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Lindegaard PM, Krüger M, Grimm D, et al. The prostacyclin analogue treprostinil in the treatment of pulmonary arterial hypertension[J]. Basic Clin Pharmacol Toxicol, 2020, 126(1): 32-42., articleTitle=null, refAbstract=null), Reference(id=1329527034335834478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Barst RJ, McGoon M, McLaughlin V, et al. Beraprost therapy for pulmonary arterial hypertension[J]. J Am Coll Cardiol, 2003, 41(12): 2119-2125., articleTitle=null, refAbstract=null), Reference(id=1329527034428109167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Galiè N, Humbert M, Vachiéry JL, et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial[J]. J Am Coll Cardiol, 2002, 39(9): 1496-1502., articleTitle=null, refAbstract=null), Reference(id=1329527034532966768, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Ono F, Nagaya N, Kyotani S, et al. Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension[J]. Circ J, 2003, 67(5): 375-378., articleTitle=null, refAbstract=null), Reference(id=1329527034600075633, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Kunieda T, Nakanishi N, Matsubara H, et al. Effects of long-acting beraprost sodium (TRK-100STP) in Japanese patients with pulmonary arterial hypertension[J]. Int Heart J, 2009, 50(4): 513-529., articleTitle=null, refAbstract=null), Reference(id=1329527034667184498, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Genecand L, Wacker J, Beghetti M, et al. Selexipag for the treatment of pulmonary arterial hypertension[J]. Expert Rev Respir Med, 2021, 15(5): 583-595., articleTitle=null, refAbstract=null), Reference(id=1329527034738487667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Simonneau G, Torbicki A, Hoeper MM, et al. Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension[J]. Eur Respir J, 2012, 40(4): 874-880., articleTitle=null, refAbstract=null), Reference(id=1329527034809790836, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Sitbon O, Channick R, Chin KM, et al. Selexipag for the treatment of pulmonary arterial hypertension[J]. N Engl J Med, 2015, 373(26): 2522-2533., articleTitle=null, refAbstract=null), Reference(id=1329527034893676917, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Frost A, Janmohamed M, Fritz JS, et al. Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: results from the TRANSIT-1 study[J]. J Heart Lung Transplant, 2019, 38(1): 43-50., articleTitle=null, refAbstract=null), Reference(id=1329527035023700343, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Chin KM, Sitbon O, Doelberg M, et al. Three- versus two-drug therapy for patients with newly diagnosed pulmonary arterial hypertension[J]. J Am Coll Cardiol, 2021, 78(14): 1393-1403., articleTitle=null, refAbstract=null), Reference(id=1329527035107586424, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Tran TA, Kramer B, Shin YJ, et al. Discovery of 2-(((1r, 4r)-4-(((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl) cyclohexyl)methoxy) acetate (ralinepag): an orally active prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension[J]. J Med Chem, 2017, 60(3): 913-927., articleTitle=null, refAbstract=null), Reference(id=1329527035204055417, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Grundy JS, King CD, Adams JW, et al. Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers[J]. Pulm Circ, 2020, 10(2): 2045894020922814., articleTitle=null, refAbstract=null), Reference(id=1329527035317301626, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Torres F, Farber H, Ristic A, et al. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial[J]. Eur Respir J, 2019, 54(4): 1901030., articleTitle=null, refAbstract=null), Reference(id=1329527035401187707, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Orie NN, Ledwozyw A, Williams DJ, et al. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins[J]. Prostaglandins Other Lipid Mediat, 2013, 106: 1-7., articleTitle=null, refAbstract=null), Reference(id=1329527035489268092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Kuwano K, Hashino A, Noda K, et al. A long-acting and highly selective prostacyclin receptor agonist prodrug, 2-(4-((5, 6-diphenylpyrazin-2-yl)(isopropyl)amino) butoxy)-N-(methylsulfonyl) acetamide (NS-304), ameliorates rat pulmonary hypertension with unique relaxant responses of its active form, (4-((5, 6-diphenylpyrazin-2-yl)(isopropyl) amino)butoxy) acetic acid (MRE-269), on rat pulmonary artery[J]. J Pharmacol Exp Ther, 2008, 326(3): 691-699., articleTitle=null, refAbstract=null), Reference(id=1329527035568959869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Roberts MJ, May LT, Keen AC, et al. Inhibition of the proliferation of human lung fibroblasts by prostacyclin receptor agonists is linked to a sustained cAMP signal in the nucleus[J]. Front Pharmacol, 2021, 12: 669227., articleTitle=null, refAbstract=null), Reference(id=1329527035682206078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Maruyama H, Sakai S, Dewachter L, et al. Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation[J]. Life Sci, 2023, 315: 121372., articleTitle=null, refAbstract=null), Reference(id=1329527035778675071, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Ichikawa T, Yamada T, Treiber A, et al. Cross-species comparison of the metabolism and excretion of selexipag[J]. Xenobiotica, 2019, 49(3): 284-301., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.04.017, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.04.017, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.04.017, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.04.017, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1712678400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
口服前列腺素治疗肺动脉高压研究进展
李义 , 伍广伟 , 朱海通 , 黄梦怡
世界临床药物 | 综述评论 2024,45(4): 440-444
收起
收藏切换
世界临床药物 |综述评论 2024 , 45 (4) : 440 -444
口服前列腺素治疗肺动脉高压研究进展
全屏
[Author(id=1329527026458931518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527026551206208, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026458931518, language=EN, stringName=Yi LI, firstName=Yi, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527026630897985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026458931518, language=CN, stringName=李义, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=广西壮族自治区人民医院心血管内科,广西 南宁 530016, bio={"content":"

李义,主治医师,研究方向:肺动脉高压诊治。

"}, bioImg=null, bioContent=

李义,主治医师,研究方向:肺动脉高压诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])]), Author(id=1329527026710589763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527026790281541, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026710589763, language=EN, stringName=Guangwei WU, firstName=Guangwei, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527026874167622, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026710589763, language=CN, stringName=伍广伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=广西壮族自治区人民医院心血管内科,广西 南宁 530016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])]), Author(id=1329527026991608136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527027092271434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026991608136, language=EN, stringName=Haitong ZHU, firstName=Haitong, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527027180351819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527026991608136, language=CN, stringName=朱海通, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=广西壮族自治区人民医院心血管内科,广西 南宁 530016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])]), Author(id=1329527027264237901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527027360706895, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527027264237901, language=EN, stringName=Mengyi HUANG, firstName=Mengyi, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527027452981584, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, authorId=1329527027264237901, language=CN, stringName=黄梦怡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=广西壮族自治区人民医院心血管内科,广西 南宁 530016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527026366656826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, xref=null, ext=[AuthorCompanyExt(id=1329527026375045435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China), AuthorCompanyExt(id=1329527026383434044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527025729122615, companyId=1329527026366656826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=广西壮族自治区人民医院心血管内科,广西 南宁 530016)])])]
李义, 伍广伟, 朱海通, 黄梦怡
作者信息
  • 广西壮族自治区人民医院心血管内科,广西 南宁 530016
作者简介:

李义,主治医师,研究方向:肺动脉高压诊治。

Research progress on oral prostaglandin in the treatment of pulmonary hypertension
Yi LI, Guangwei WU, Haitong ZHU, Mengyi HUANG
Affiliations
  • Department of Cardiovascular Medicine, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530016, Guangxi Zhuang Autonomous Region, China
出版时间: 2024-04-10 doi: 10.13683/j.wph.2024.04.017
文章导航
收藏切换

肺动脉高压(pulmonary arterial hypertension,PAH)是一种进行性的、治愈难度大的疾病,其特征为肺小动脉的收缩与重塑,同时伴肺动脉压力增加。随着PAH进展,右心室负荷增加,最终发展为心力衰竭(heart failure)。口服前列腺素(prostaglandin,PG)及其类似物能改善PAH临床症状、降低恶化/死亡风险、延缓疾病进展,且相对安全、方便,患者依从性高。现对口服PG治疗PAH机制及应用相关文献进行综述,为临床提供决策依据。

口服前列腺素  /  肺动脉高压  /  曲前列环素  /  贝前列腺素  /  司来帕格  /  雷利帕格

Pulmonary arterial hypertension (PAH) is a progressive and treatable disease characterized by contraction and remodeling of pulmonary arteriole accompanied by increased pulmonary arterial pressure. As PAH progresses, the load on the right ventricle increases, eventually leading to heart failure. Oral prostaglandin (PG) and their analogues can improve the clinical symptoms of PAH, reduce the risk of deterioration or death, delay disease progression, and are relatively safe, convenient, and have high patient compliance. This article reviewed the mechanism and application of oral PG in the treatment of PAH and provided a basis for clinical application.

oral prostaglandin  /  pulmonary arterial hypertension  /  troprostacycline  /  bayprostaglandin  /  selexipag  /  ralinepag
李义, 伍广伟, 朱海通, 黄梦怡. 口服前列腺素治疗肺动脉高压研究进展. 世界临床药物, 2024 , 45 (4) : 440 -444 . DOI: 10.13683/j.wph.2024.04.017
Yi LI, Guangwei WU, Haitong ZHU, Mengyi HUANG. Research progress on oral prostaglandin in the treatment of pulmonary hypertension[J]. World Clinical Drug, 2024 , 45 (4) : 440 -444 . DOI: 10.13683/j.wph.2024.04.017

参考文献 引证文献
排序方式:
[1]
Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Respir J, 2023, 61(1): 2200879.
[2]
Gelzinis TA. Pulmonary hypertension in 2021: part Ⅰ- definition, classification, pathophysiology, and presentation[J]. J Cardiothorac Vasc Anesth, 2022, 36(6): 1552-1564.
[3]
Safdar Z. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs[J]. Respir Med, 2011, 105(6): 818-827.
[4]
Mandras S, Kovacs G, Olschewski H, et al. Combination therapy in pulmonary arterial hypertension-targeting the nitric oxide and prostacyclin pathways[J]. J Cardiovasc Pharmacol Ther, 2021, 26(5): 453-462.
[5]
Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review[J]. J Am Med Assoc, 2022, 327(14): 1379-1391.
[6]
王志伟, 韩宇, 程江涛. 司来帕格在肺动脉高压治疗中的应用[J]. 中国药房, 2022, 33(16): 2040-2043.
[7]
Mubarak KK. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension[J]. Respir Med, 2010, 104(1): 9-21.
[8]
Tuder RM, Cool CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension[J]. Am J Respir Crit Care Med, 1999, 159(6): 1925-1932.
[9]
Patel JA, Shen L, Hall SM, et al. Prostanoid EP2 receptors are up-regulated in human pulmonary arterial hypertension: a key anti-proliferative target for treprostinil in smooth muscle cells[J]. Int J Mol Sci, 2018, 19(8): 2372.
[10]
Mulvaney EP, Reid HM, Bialesova L, et al. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension[J]. Bio Med Central Pulm Med, 2020, 20(1): 85.
[11]
陈雨思, 李江. 前列环素类药物治疗肺动脉高压的研究进展[J]. 医药导报, 2022, 41(2): 195-200.
[12]
Tapson VF, Torres F, Kermeen F, et al. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial[J]. Chest, 2012, 142(6): 1383-1390.
[13]
Tapson VF, Jing Z, Xu K, et al. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study)[J]. Chest, 2013, 144(3): 952-958.
[14]
White RJ, Jerjes-Sanchez C, Bohns Meyer GM, et al. Combination therapy with oral treprostinil for pulmonary arterial hypertension. A double-blind placebo-controlled clinical trial[J]. Am J Respir Crit Care Med, 2020, 201(6): 707-717.
[15]
Khan A, White RJ, Meyer G, et al. Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension[J]. Respiratory Medicine, 2022, 193: 106744.
[16]
White RJ, Parikh K, Allen R, et al. EXPRESS: long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics[J]. Pulm Circ, 2019, 10(4): 2045894019866335.
[17]
Lindegaard PM, Krüger M, Grimm D, et al. The prostacyclin analogue treprostinil in the treatment of pulmonary arterial hypertension[J]. Basic Clin Pharmacol Toxicol, 2020, 126(1): 32-42.
[18]
Barst RJ, McGoon M, McLaughlin V, et al. Beraprost therapy for pulmonary arterial hypertension[J]. J Am Coll Cardiol, 2003, 41(12): 2119-2125.
[19]
Galiè N, Humbert M, Vachiéry JL, et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial[J]. J Am Coll Cardiol, 2002, 39(9): 1496-1502.
[20]
Ono F, Nagaya N, Kyotani S, et al. Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension[J]. Circ J, 2003, 67(5): 375-378.
[21]
Kunieda T, Nakanishi N, Matsubara H, et al. Effects of long-acting beraprost sodium (TRK-100STP) in Japanese patients with pulmonary arterial hypertension[J]. Int Heart J, 2009, 50(4): 513-529.
[22]
Genecand L, Wacker J, Beghetti M, et al. Selexipag for the treatment of pulmonary arterial hypertension[J]. Expert Rev Respir Med, 2021, 15(5): 583-595.
[23]
Simonneau G, Torbicki A, Hoeper MM, et al. Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension[J]. Eur Respir J, 2012, 40(4): 874-880.
[24]
Sitbon O, Channick R, Chin KM, et al. Selexipag for the treatment of pulmonary arterial hypertension[J]. N Engl J Med, 2015, 373(26): 2522-2533.
[25]
Frost A, Janmohamed M, Fritz JS, et al. Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: results from the TRANSIT-1 study[J]. J Heart Lung Transplant, 2019, 38(1): 43-50.
[26]
Chin KM, Sitbon O, Doelberg M, et al. Three- versus two-drug therapy for patients with newly diagnosed pulmonary arterial hypertension[J]. J Am Coll Cardiol, 2021, 78(14): 1393-1403.
[27]
Tran TA, Kramer B, Shin YJ, et al. Discovery of 2-(((1r, 4r)-4-(((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl) cyclohexyl)methoxy) acetate (ralinepag): an orally active prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension[J]. J Med Chem, 2017, 60(3): 913-927.
[28]
Grundy JS, King CD, Adams JW, et al. Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers[J]. Pulm Circ, 2020, 10(2): 2045894020922814.
[29]
Torres F, Farber H, Ristic A, et al. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial[J]. Eur Respir J, 2019, 54(4): 1901030.
[30]
Orie NN, Ledwozyw A, Williams DJ, et al. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins[J]. Prostaglandins Other Lipid Mediat, 2013, 106: 1-7.
[31]
Kuwano K, Hashino A, Noda K, et al. A long-acting and highly selective prostacyclin receptor agonist prodrug, 2-(4-((5, 6-diphenylpyrazin-2-yl)(isopropyl)amino) butoxy)-N-(methylsulfonyl) acetamide (NS-304), ameliorates rat pulmonary hypertension with unique relaxant responses of its active form, (4-((5, 6-diphenylpyrazin-2-yl)(isopropyl) amino)butoxy) acetic acid (MRE-269), on rat pulmonary artery[J]. J Pharmacol Exp Ther, 2008, 326(3): 691-699.
[32]
Roberts MJ, May LT, Keen AC, et al. Inhibition of the proliferation of human lung fibroblasts by prostacyclin receptor agonists is linked to a sustained cAMP signal in the nucleus[J]. Front Pharmacol, 2021, 12: 669227.
[33]
Maruyama H, Sakai S, Dewachter L, et al. Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation[J]. Life Sci, 2023, 315: 121372.
[34]
Ichikawa T, Yamada T, Treiber A, et al. Cross-species comparison of the metabolism and excretion of selexipag[J]. Xenobiotica, 2019, 49(3): 284-301.
2024年第45卷第4期
16
3
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.04.017
  • 接收时间:2023-05-16
  • 首发时间:2026-11-17
  • 出版时间:2024-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-05-16
  • 修回日期:2024-01-12
基金
作者信息
    广西壮族自治区人民医院心血管内科,广西 南宁 530016
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.04.017
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏